About us

Scientific potential of The Children’s Memorial Health Institute

The Children’s Memorial Health Institute conducts its scientific activities based on its clinical activities. The clinical structure of the Institute includes 26 hospital wards, 30 specialized clinics, 8 diagnostic facilities, an operating theater with 10 rooms. There are 618 hospital beds available. The CMHI (in polish: IPCZD) performs 91,000 hospitalizations annually, 170,000 consultations in specialized clinics, covering all areas of pediatric medicine, with the exception of hematology and orthopedics. The CMHI treats patients from across Poland, 50% of which is from the Mazovian district. The Institute performs annually 12,000 procedures under general anesthesia and 7,000 surgical operations.

The Institute has got a scientific category A and HR Logo certificate. It is an active member of 7 ERN’s (European Rare Desease Networks): EpiCARE, TRANSPLANTCHILD, ITHACA, MetabERN, PaedCan-ERN, RARE-LIVER, RITA.

The CMHI employed 90 researchers, including positions of Institute Prof. and Prof. (34 people), Assistant Prof. (24 people) and Research Assistant (29 people). Annually, about 255 scientific publications are being prepared, to 130 of which has been assigned the Impact Factor. The total value for the Institute is amounting to 655.600 IF (status for 2025).

The Institute carries out projects financed by subsidies from the Ministry of Science and Higher Education, external domestic funds (NCN, NCBiR, ABM) and EU funds.

Department of Scientific Research (DSR) coordinates all scientific projects in CMHI nauka@ipczd.pl.

CMHI, as a hospital and a research unit with the highest level of reference in Poland, is a leader in conducting modern clinical trials (BK) in the paediatric population. The Minister of Health appointed CMHI as the coordinator of the Polish Network of Clinical Trials in Pediatrics (POLPEDNET).

CMHI conducts approximately 80 commercial clinical and observational trials annually. The institute is currently participating in nine non-commercial clinical trials funded by ABM, with the acronyms: DIPGen, BraimTOR Onko, BraimTOR Neuro, VIRAP, RaRE-TS, EMPATia, AxGD, PRIFEN, and VEDi-UC.
CMHI researchers are experts who are recognised by the pharmaceutical industry as Key Opinion Leaders.

Thanks to funding from ABM, was established Pediatric Clinical Trials Support Center (PCTSC), in order to comprehensively support the conduct of clinical research at the Institute.  To implement the NCT, PCTSC acts as an ACRO, acting on behalf of the sponsor, and its staff (PCTSC Manager, PCTSC Specialist for Quality, Pharmacovigilance, Monitoring, Study Coordination) supervise the work of the people hired specifically for each project, among others, CTA, Pharmacovigilance, data manager, monitor, site coordinator).

Project implementation is based on cooperation between the Research Department and Pediatric Clinical Trials Support Center with relevant units of the Institute, including the Purchasing Department, the Public Procurement Department, the Accounting Department, and the Human Resources and Remuneration Department, in accordance with the Public Procurement Law, regulations, orders, and the Standard Operating Procedures of the CMHI Quality Management System.

Currently, the CMHI is implementing a Pediatric Regional Digital Medicine Center with a biobank.